Merck: FDA Wants More Studies Of Insomnia Drug
WHITEHOUSE STATION, N.J. (AP) — Drugmaker Merck & Co. says federal regulators have ruled that they won't approve high doses of its experimental insomnia medication because of concerns about their safety.